What is Plastic Surgery Group?
Operating within the specialized Physicians Clinics industry, Plastic Surgery Group serves as a critical provider of aesthetic and reconstructive medical services. With a dedicated workforce of 20 to 49 professionals, the company has established a consistent revenue stream ranging between 1M and 5M. Its market position is defined by a commitment to high-quality patient care and clinical precision, allowing it to maintain a competitive edge in the regional healthcare sector. The firm's ability to secure institutional debt financing highlights its maturity and the scalability of its business model in an increasingly consolidated healthcare environment.
How much funding has Plastic Surgery Group raised?
Plastic Surgery Group has raised a total of $337K across 2 funding rounds:
Debt
$150K
Debt
$187K
Debt (2020): $150K with participation from PPP
Debt (2021): $187K led by PPP
Key Investors in Plastic Surgery Group
PPP
Public-Private Partnership
What's next for Plastic Surgery Group?
Looking ahead, the deployment of this capital is expected to focus on optimizing clinical infrastructure and expanding service capabilities to meet rising demand. As the company navigates its late-stage growth phase, management will likely prioritize operational efficiencies and potential service line diversification. By maintaining a disciplined approach to debt management and reinvestment, Plastic Surgery Group is well-positioned to enhance its market share and continue its trajectory as a leading provider of specialized surgical care in the New Jersey region. Future strategic initiatives will likely center on technological integration and patient acquisition strategies to drive long-term value.
See full Plastic Surgery Group company page
